skip to content
Covid-19 virus
COVID-19 Resources

Reliable information about the coronavirus (COVID-19) is available from the World Health Organization (current situation, international travel). Numerous and frequently-updated resource results are available from this WorldCat.org search. OCLC’s WebJunction has pulled together information and resources to assist library staff as they consider how to handle coronavirus issues in their communities.

Image provided by: CDC/ Alissa Eckert, MS; Dan Higgins, MAM
Resilience at InterMune : a journey through the valley of the shadow of death Preview this item
ClosePreview this item
Checking...

Resilience at InterMune : a journey through the valley of the shadow of death

Author: Homa Bharami
Publisher: London : SAGE Publications Ltd, 2017.
Series: SAGE Knowledge., Cases.
Edition/Format:   eBook : Document : EnglishView all editions and formats
Summary:
This case study is about a California-based biotechnology company that has experienced many ups and downs throughout its 17-year history. Despite many setbacks, it ultimately succeeded in developing and getting approval for an orphan drug used to treat IPF, a deadly lung disease. InterMune was acquired by Roche/Genentech for $8.3 billion in September 2014; the price represented a significant premium over InterMunes  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Case studies
Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Homa Bharami
ISBN: 9781526407894 1526407892
OCLC Number: 1017727083
Notes: Originally published: Bahrami, H. (2015). Resilience at InterMune: A journey through the valley of the shadow of death. The Berkeley-Haas Case Series. University of California, Berkeley. Haas School of Business.
Description: 1 online resource : illustrations.
Series Title: SAGE Knowledge., Cases.
Responsibility: Homa Bharami.

Abstract:

This case study is about a California-based biotechnology company that has experienced many ups and downs throughout its 17-year history. Despite many setbacks, it ultimately succeeded in developing and getting approval for an orphan drug used to treat IPF, a deadly lung disease. InterMune was acquired by Roche/Genentech for $8.3 billion in September 2014; the price represented a significant premium over InterMunes trading price at the time. The protagonist, InterMunes CEO, Dan Welch, joined the company in 2003 and has led InterMune through numerous strategic pivots, leadership changes, clinical trial disappointments, multiple divestitures, and ultimately the sale of the company. Resilience and the capacity to bounce back are at the core of this case study. The narrative focuses on strategic, cultural, and leadership changes and decisions made by Welch, the Board and the leadership team throughout Welchs tenure. Specifically, Welch sharpened InterMunes strategic focus on a few indications, evolved the Board and the leadership team, and orchestrated a grassroots initiative to re-invent InterMunes core values and cultural pillars.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


\n\n

Primary Entity<\/h3>\n
<http:\/\/www.worldcat.org\/oclc\/1017727083<\/a>> # Resilience at InterMune : a journey through the valley of the shadow of death<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Book<\/a>, schema:MediaObject<\/a>, schema:CreativeWork<\/a> ;\u00A0\u00A0\u00A0\nlibrary:oclcnum<\/a> \"1017727083<\/span>\" ;\u00A0\u00A0\u00A0\nlibrary:placeOfPublication<\/a> <http:\/\/id.loc.gov\/vocabulary\/countries\/enk<\/a>> ;\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/4705977396#Topic\/success_in_business<\/a>> ; # Success in business<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/4705977396#Topic\/small_business_united_states_growth<\/a>> ; # Small business--United States--Growth<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/4705977396#Organization\/intermune<\/a>> ; # InterMune.<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/4705977396#Topic\/success_in_business_united_states<\/a>> ; # Success in business--United States<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/4705977396#Topic\/biotechnology_industry_united_states<\/a>> ; # Biotechnology industry--United States<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/dewey.info\/class\/338.76151092\/<\/a>> ;\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/4705977396#Place\/united_states<\/a>> ; # United States.<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/4705977396#Topic\/small_business_growth<\/a>> ; # Small business--Growth<\/span>\n\u00A0\u00A0\u00A0\nschema:author<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/4705977396#Person\/bharami_homa<\/a>> ; # Homa Bharami<\/span>\n\u00A0\u00A0\u00A0\nschema:bookFormat<\/a> schema:EBook<\/a> ;\u00A0\u00A0\u00A0\nschema:datePublished<\/a> \"2017<\/span>\" ;\u00A0\u00A0\u00A0\nschema:description<\/a> \"This case study is about a California-based biotechnology company that has experienced many ups and downs throughout its 17-year history. Despite many setbacks, it ultimately succeeded in developing and getting approval for an orphan drug used to treat IPF, a deadly lung disease. InterMune was acquired by Roche\/Genentech for $8.3 billion in September 2014; the price represented a significant premium over InterMunes trading price at the time. The protagonist, InterMunes CEO, Dan Welch, joined the company in 2003 and has led InterMune through numerous strategic pivots, leadership changes, clinical trial disappointments, multiple divestitures, and ultimately the sale of the company. Resilience and the capacity to bounce back are at the core of this case study. The narrative focuses on strategic, cultural, and leadership changes and decisions made by Welch, the Board and the leadership team throughout Welchs tenure. Specifically, Welch sharpened InterMunes strategic focus on a few indications, evolved the Board and the leadership team, and orchestrated a grassroots initiative to re-invent InterMunes core values and cultural pillars.<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\nschema:exampleOfWork<\/a> <http:\/\/worldcat.org\/entity\/work\/id\/4705977396<\/a>> ;\u00A0\u00A0\u00A0\nschema:genre<\/a> \"Case studies<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\nschema:inLanguage<\/a> \"en<\/span>\" ;\u00A0\u00A0\u00A0\nschema:isPartOf<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/4705977396#Series\/sage_knowledge<\/a>> ; # SAGE Knowledge.<\/span>\n\u00A0\u00A0\u00A0\nschema:isPartOf<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/4705977396#Series\/sage_knowledge_cases<\/a>> ; # SAGE Knowledge. Cases<\/span>\n\u00A0\u00A0\u00A0\nschema:name<\/a> \"Resilience at InterMune : a journey through the valley of the shadow of death<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\nschema:productID<\/a> \"1017727083<\/span>\" ;\u00A0\u00A0\u00A0\nschema:url<\/a> <http:\/\/sk.sagepub.com\/cases\/resilience-at-intermune-journey-the-valley-of-the-shadow-of-death<\/a>> ;\u00A0\u00A0\u00A0\nschema:workExample<\/a> <http:\/\/worldcat.org\/isbn\/9781526407894<\/a>> ;\u00A0\u00A0\u00A0\nwdrs:describedby<\/a> <http:\/\/www.worldcat.org\/title\/-\/oclc\/1017727083<\/a>> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n\n

Related Entities<\/h3>\n
<http:\/\/dewey.info\/class\/338.76151092\/<\/a>>\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/4705977396#Organization\/intermune<\/a>> # InterMune.<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Organization<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"InterMune.<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/4705977396#Person\/bharami_homa<\/a>> # Homa Bharami<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Person<\/a> ;\u00A0\u00A0\u00A0\nschema:familyName<\/a> \"Bharami<\/span>\" ;\u00A0\u00A0\u00A0\nschema:givenName<\/a> \"Homa<\/span>\" ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Homa Bharami<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/4705977396#Place\/united_states<\/a>> # United States.<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Place<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"United States.<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/4705977396#Series\/sage_knowledge<\/a>> # SAGE Knowledge.<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nbgn:PublicationSeries<\/a> ;\u00A0\u00A0\u00A0\nschema:hasPart<\/a> <http:\/\/www.worldcat.org\/oclc\/1017727083<\/a>> ; # Resilience at InterMune : a journey through the valley of the shadow of death<\/span>\n\u00A0\u00A0\u00A0\nschema:name<\/a> \"SAGE Knowledge.<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/4705977396#Series\/sage_knowledge_cases<\/a>> # SAGE Knowledge. Cases<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nbgn:PublicationSeries<\/a> ;\u00A0\u00A0\u00A0\nschema:hasPart<\/a> <http:\/\/www.worldcat.org\/oclc\/1017727083<\/a>> ; # Resilience at InterMune : a journey through the valley of the shadow of death<\/span>\n\u00A0\u00A0\u00A0\nschema:name<\/a> \"SAGE Knowledge. Cases<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/4705977396#Topic\/biotechnology_industry_united_states<\/a>> # Biotechnology industry--United States<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Biotechnology industry--United States<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/4705977396#Topic\/small_business_growth<\/a>> # Small business--Growth<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Small business--Growth<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/4705977396#Topic\/small_business_united_states_growth<\/a>> # Small business--United States--Growth<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Small business--United States--Growth<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/4705977396#Topic\/success_in_business<\/a>> # Success in business<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Success in business<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/4705977396#Topic\/success_in_business_united_states<\/a>> # Success in business--United States<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Success in business--United States<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/id.loc.gov\/vocabulary\/countries\/enk<\/a>>\u00A0\u00A0\u00A0\u00A0a \nschema:Place<\/a> ;\u00A0\u00A0\u00A0\ndcterms:identifier<\/a> \"enk<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/worldcat.org\/isbn\/9781526407894<\/a>>\u00A0\u00A0\u00A0\u00A0a \nschema:ProductModel<\/a> ;\u00A0\u00A0\u00A0\nschema:isbn<\/a> \"1526407892<\/span>\" ;\u00A0\u00A0\u00A0\nschema:isbn<\/a> \"9781526407894<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/www.worldcat.org\/title\/-\/oclc\/1017727083<\/a>>\u00A0\u00A0\u00A0\u00A0a \ngenont:InformationResource<\/a>, genont:ContentTypeGenericResource<\/a> ;\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/www.worldcat.org\/oclc\/1017727083<\/a>> ; # Resilience at InterMune : a journey through the valley of the shadow of death<\/span>\n\u00A0\u00A0\u00A0\nschema:dateModified<\/a> \"2019-02-09<\/span>\" ;\u00A0\u00A0\u00A0\nvoid:inDataset<\/a> <http:\/\/purl.oclc.org\/dataset\/WorldCat<\/a>> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n\n

Content-negotiable representations<\/p>\n